Effectiveness of Corticosteroids in Treating Chemotherapy-Induced Thrombocytopenia
Researchers sought to determine whether corticosteroids would be an effective treatment for patients with chemotherapy-induced thrombocytopenia.
Researchers sought to determine whether corticosteroids would be an effective treatment for patients with chemotherapy-induced thrombocytopenia.
Risk reduced for lobar and nonlobar intracerebral hemorrhage; greater reductions seen with prolonged use ≥5 years
The approval was based on data from the HOPE-B trial that included 54 male participants with severe or moderately severe hemophilia B.
Efanesoctocog alfa is a novel recombinant factor VIII therapy designed to extend protection from bleeds by breaking the von Willebrand factor ceiling.
Rebinyn is a recombinant DNA-derived coagulation Factor IX concentrate with an extended half-life.
Etranacogene dezaparvovec is an investigational gene therapy that uses AAV5 to carry the Padua gene variant of factor IX.
The phase 3 ADVANCE trial evaluated the efficacy and safety of efgartigimod in 131 adults with primary ITP.
Apixaban is a direct oral anticoagulant that relies less on kidney excretion.
But, though difference is small, tranexamic acid not noninferior to placebo for primary safety outcome of composite cardiovascular outcome
In preclinical studies, ASC618 has been shown to have at least a 10-fold increase in the biosynthesis and secretion of FVIII compared with native human FVIII bioengineered constructs.